PHARMACYTE BIOTECH INC's ticker is PMCBD and the CUSIP is 71715X203. A total of 29 filers reported holding PHARMACYTE BIOTECH INC in Q2 2023. The put-call ratio across all filers is 7.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $173,727 | -1.1% | 82,727 | +34.7% | 0.04% | -18.9% |
| Q2 2023 | $175,647 | -81.7% | 61,415 | -81.4% | 0.05% | -88.3% |
| Q1 2023 | $962,320 | -0.7% | 330,694 | 0.0% | 0.45% | +47.9% |
| Q4 2022 | $968,933 | +22.0% | 330,694 | 0.0% | 0.31% | +46.9% |
| Q3 2022 | $794,000 | +3.4% | 330,694 | -3.6% | 0.21% | -4.1% |
| Q2 2022 | $768,000 | +8.0% | 342,994 | +10.9% | 0.22% | +40.6% |
| Q1 2022 | $711,000 | +9.9% | 309,294 | +19.6% | 0.16% | +78.2% |
| Q4 2021 | $647,000 | – | 258,694 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayrton Capital LLC | 1,033,130 | $3,027,071 | 8.27% |
| K2 PRINCIPAL FUND, L.P. | 732,105 | $2,145,068 | 0.33% |
| EQUITEC PROPRIETARY MARKETS, LLC | 330,694 | $968,933 | 0.31% |
| SABBY MANAGEMENT, LLC | 97,978 | $287,076 | 0.25% |
| FNY Investment Advisers, LLC | 31,100 | $90 | 0.13% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 40,800 | $119,544 | 0.02% |
| Aspire Private Capital, LLC | 800 | $2,344 | 0.00% |
| Schonfeld Strategic Advisors LLC | 25,200 | $73,836 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,758 | $6,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 98 | $286 | 0.00% |